SCHEMBL7293924

SCHEMBL7293924

CC(C)OC(=O)C(O)CCC1CCCC(N)C1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8895979 0.82 METAP2 (0.45) METAP2
SCHEMBL9386500 0.79 SLC1A3 (0.35) —
SCHEMBL8201992 0.71 METAP2 (0.42) METAP2
SCHEMBL8282730 0.71 METAP2 (0.42) METAP2
SCHEMBL7446286 0.69 LTB4R (0.33) —
SCHEMBL16732255 0.69 METAP2 (0.41) METAP2
SCHEMBL16732152 0.68 METAP2 (0.43) METAP2
SCHEMBL6882316 0.67 HPGD (0.41) —
SCHEMBL6882320 0.67 HPGD (0.41) —
SCHEMBL6882324 0.67 HPGD (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5164388-A Hypotensive agents, treatment of congestive heart failure ABBOTT LABORATORIES (US) 1992-11-17 — — US disclosed
EP-0439556-A4 HETEROCYCLIC PEPTIDE RENIN INHIBITORS — 1991-10-30 — — EP disclosed
EP-0439556-A1 HETEROCYCLIC PEPTIDE RENIN INHIBITORS ABBOTT LABORATORIES (US) 1991-08-07 — — EP disclosed
WO-1990004917-A1 HETEROCYCLIC PEPTIDE RENIN INHIBITORS ABBOTT LABORATORIES (US) 1990-05-17 — — WO disclosed
EP-0365992-A1 Heterocyclic peptide renin inhibitors ABBOTT LABORATORIES (US) 1990-05-02 — — EP disclosed
Send feedback